Articles posted by Emily Mulvihill

Emily Mulvihill

Emily Mulvihill, Senior Consultant with Kantar Health, has over 15 years of experience directing primary market research in the pharmaceutical industry. Ms. Mulvihill

09 - July
2011
Issues
Market Access
Marketing Strategy

Pricing for Indication Launch Sequence: Three Key Questions

What drives profits for a new pharmaceutical? Price. Optimizing the profits of a pharmaceutical ...

Emily Mulvihill July 1, 2011

Emily Mulvihill

Pricing for Indication Launch Sequence: Three Key Questions

Experts on Call

Click to continue to site. Closing